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Feline Borna disease, a neurological disease of cats is an infection caused by 
Borna disease virus (BDV). The infection, first reported in Sweden in 1974, 
affects other species of animals such as horses in which the disease was first 
reported. Sheep is the other natural host of the virus, but BDV infection is also 
seen in cattle, dogs, goats, donkey, and some zoo animals. The disease is widely 
speculated to be zoonotic as it is believed to affect humans as well. In Sweden, the 
infection is endemic in central part of Sweden namely in the Stockholm and 
Uppsala area, where numerous cases have been reported in the past and new cases 
continue to emerge in recent times. The importance and continued incidence and 
prevalence of the infection in cat prompted this present study. Archive and 
incoming samples from cats, horses and dogs were screened by real- time RT-
PCR. Eight positive cat samples were detected by real-time RT-PCR. Three of 
these samples were used for virus isolation and characterization, while two other 
positive samples were used to test previously described primers. In conclusion, we 
have been able to detect eight positive samples from the cat by real-time RT-PCR. 
Though the virus was not detected upon sub-passages in vero cells, demonstration 
of presence of the virus from passage 10-12 in the positive control show that other 
factors than the assay may have contributed to the lack of virus isolation The 
classical PCR for molecular epidemiology needs further optimization as reflected 
in the fact that only three primer pairs seem to work with the C6BDV control 
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Viral infections such as rabies, cowpox and smallpox have been known to affect 
domestic animals and humans for ages. These infections have deleterious effects 
on the health and wellbeing of humans and animals and are of grave economic 
importance. They pose serious public health significance not only to individuals 
and animals but also to the society in general. Borna disease (BD), a fatal T-cell 
mediated immunopathological disease affecting the central nervous system, was 
originally recognised in horses and sheep in certain areas of Germany (Durrwald 
& Ludwig, 1997), where the disease caused large scale epidemic resulting in the 
death of several thousands of horses. BD has also been diagnosed in other species 
of animals such as rabbit, cattle, dog and certain zoo animals (Bode et al., 1994; 
Lundgren et al., 1995) and a paraetic syndrome in ostrich has been reported in 
Israel (Malkinson et al., 1995). 
 
Cases of nonsuppurative meningoencephalitis in domestic cats have been reported 
in Austria, Sweden, Japan and several parts of the world (Helps et al., 2001; 
Lundgren et al., 1995; Nakamura et al., 1996; Nowotny & Weissenbock, 1995; 
Reeves et al., 1998). The present project focussed primarily on the detection and 
characterization of feline Borna disease virus in Sweden. The emphasis in this 
study was the use of molecular techniques to gain a better understanding of BDV, 
in order to address the situation as regards feline Borna disease in Sweden. 
Introduction 
History 
In the 18th and 19th centuries in southern Germany, clinical signs in horses similar 
to that of Borna disease were first described. This was the first record of its kind as 
regards to BD in any part of the world. There had been an epidemic like outbreak 
in the 1890 and the first decade of the 20th century in the city of Borna, near 
Leipzig, Germany, where a large number of horses had died from the disease. The 
name Bornasche Krankheit (Borna disease) was coined from the district around 
the city where the epidemic had occurred. In the 1920s, the aetiology of the 
disease was demonstrated to be a virus (reviewed in Durrwald & Ludwig, 1997; 
Ludwig & Bode, 2000). As early as the 1950s, feline cases of nonsuppurative 
meningoencephalitis had been reported in different parts of the world (Hoff & 
Vandevelde, 1981; Mcgaughey, 1953; Truyen et al., 1990). At that time the 
disease was poorly defined and the aetiology although unknown, was assumed to 
be of viral origin. However, in 1974, a feline neurological disorder of cat with an 
unknown aetiology was described in Sweden (Kronevi et al., 1974). Cases of 
feline meningoencephalitis commonly called vingelsjuka in Swedish (staggering 
disease) continue to occur in mid-Sweden even till date. In the 1990s, staggering 





The etiological agent, Borna disease virus (BDV), is a single-stranded negative-
sense enveloped non-segmented RNA virus (Briese et al., 1994; Cubitt et al., 
1994) and is the prototypic member of the new family Bornaviridae, within the 
order Mononegavirales (De la Torre, 1994; Schneemann et al., 1995). The virus is 
believed to be an old evolutionary pathogen that has had time to adapt to a wide 
range of mammalian hosts. The virus is highly neurotropic, having affinity for the 
limbic system and the reticuloendothelial system. 
 
Unique features of BDV 
BDV exhibits several unique features or characteristics, among them the genome 
organisation and nucleotide sequence that are typically similar to other members 
of the order Mononegavirales. Unlike other RNA viruses which replicate and 
transcribe in the cytoplasm, nuclear localization of replication and transcription is 
typical of BDV (Pyper et al., 1998). The unusually high level of sequence 
conservation (Formella et al., 2000) is unexpected for an RNA virus that has a 
high rate of replication and transcription and thus likely to mutate often. 
 
The virus seems to have wider host range than previously thought and possibly 
affecting humans as well (Rott et al., 1985; Bode et al., 1995). The virus causes a 
persistent infection of the CNS with astrocytes primarily affected (Carbone et al., 
1989 and 1993). A characteristic feature of the infection is the development of a 
prominent astrocytosis (Gonzalez-Dunia et al., 1998; Gosztonyi & Lundwig, 
1995; Ludwig & Bode, 2000; Rott & Becht, 1995). In an inflammatory reaction of 
the brain, it is universally normal for astrocytes to respond to the inflammatory 
process irrespective of the aetiology. The primary role of astroctyes is to maintain 
the CNS microenvironment in order to ensure proper functioning of the neurons 
(Benveniste, 1992; Eddleston & Mucke, 1993; Schousboe et al., 1997). BDV 
establishes a non-cytolytic chronic infection in primary feline cortical astrocytes 
causing a severe and specific impairment in their ability to uptake glutamate 
(Billaud et al., 2000). So far, all known BDV isolates are non-cytolytic and highly 
neurotropic (Lipkin et al., 1997; Ludwig & Bode, 2000; Rott & Becht, 1995). 
 
Viral genome 
The BDV genome which is about 8.9 kb is the smallest among all known non-
segmented negative-stranded RNA viruses. The genome organisation is 
characteristic for the order Mononegavirales. It has 6 open reading frames (ORF) 
coding for 6 different proteins, i.e., p40 nucleoprotein, p24 phosphoprotein, GP18 
matrix protein, GP94 surface glycoprotein, p190 viral RNA dependent RNA 
polymerase also called the L polymerase and the 6th protein called X protein or 





BD is an immune-mediated neurological syndrome caused by a BDV. The disease 
is characterized by meningoencephalitis and usually results in disturbances in 
movement and behaviour. Natural infection with BDV in animals was originally 
described in horses and sheep in the southern region of Germany (reviewed by 
Durrwald & Ludwig, 1997) where the disease is endemic. The horse, donkey and 
sheep are natural hosts for the virus. There is evidence suggesting that BDV 
infects a wide variety of animal species and it seems that the disease is more 
widespread than previously thought (Staeheli et al., 2000). The disease has been 
recognised in cats (Lundgren and Ludwig, 1993; Lundgren et al., 1995; Nakamura 
et al., 1996), cattle (Caplazi et al., 1994), ostriches (Malkinson et al., 1995), and 
dogs (Weissenbock et al., 1998). The virus has also been isolated from a free 
ranging lynx (Lynx lynx) (Degiorgis et al., 2000), the first confirmed case of BDV-
infection in a large felid. Warmblooded primates are susceptible to experimental 
infection. The rabbit seems to be the animal of choice for experimental infections. 
However, other animal species including rats, guinea pigs, chicken, monkeys and 
tree shrews have been used in experimental studies. The routes of infection for 
most of the experiments have been intranasal and intracerebral routes because 
predictable infection could only be achieved via these routes. The clinical features 
of experimental infections differ greatly from the natural infection. In neonatally 
infected rats, BDV causes social behavioural changes with no inflammatory 
response. However, immunocompetent adult rats show similar symptoms as 
naturally infected animals. 
 
Pathogenesis 
BDV enters the cells of the host by receptor mediated endocytosis. The virus has 
two important glycoproteins (GP), GP18 and GP94 each having different 
functions in the life cycle of the virus (Gonzalez et al., 1998). GP1 plays a very 
important role in receptor recognition and virus entry, while GP2 is primarily 
responsible for fusion event for the release of the virus ribonucleoproteins. BDV 
has an affinity for neurons and replicates in the neurons. Though the overall 
mechanism of action is poorly understood, the virus spreads by centrifugal means 
via the peripheral nerves to other tissues and organs.  
 
Zoonotic potential 
Serological studies suggest that BDV may cause human infection. The relationship 
between BDV infection and human psychiatric disorders such as schizophrenia, 
mood disorders and chronic fatigue syndrome have been studied (De la Torre et 
al., 1996). Findings suggest that there might be a link between BDV infection and 
human mental disorders. Furthermore, BDV has been isolated from the brains of 
four Japanese schizophrenic patients (Nakamura et al., 2000). The virus has also 
been isolated from the brain of human patients in Germany and USA (Bode et al, 




Neither the mode of transmission nor the reservoir host of the natural infection is 
known. However, there seems to be a general consensus that the virus is 
transmitted via the olfactory route as evident by intranasal infection and 
inflammation and oedema of the olfactory bulb of naturally infected horses 
(Ludwig et al., 1988). Evidence for hematogenous transmission is founded on the 
basis that viral nucleic acids and proteins have been isolated from peripheral blood 
mononuclear cells (Rubin et al., 1995; Sierra-Honigmann et al., 1993). It is also 
possible for the virus to be transmitted vertically as BDV has been detected in a 
pregnant mare and the foetus (Hagiwara et al., 2000). There are speculations to 
indicate that vectors or reservoir hosts play a very important role in the 
transmission of the disease, as experimental infection using a rat model suggests 
that it might be possible for the virus to be transmitted from an infected host to an 
uninfected animal via secretions such as saliva, nasal secretions, urine and even 
faeces (Sauder & Staeheli, 2003). Rodents are proposed as reservoirs for BDV 
infection because experimental infection of neonatal rats results in viral 
persistence and the virus has been detectable in the saliva, urine and feaces 
(Sierra-Honigmann et al., 1993). Wild birds are also considered as candidate 
natural reservoirs for BDV since the virus has been reported in birds excrement 
(Berg et al., 2001). The bicolored white toothed shrew (Crocidura leucodon) has 
been postulated to be one possible reservoir host for BDV. In fact, the brain and 
the heart of these insectivores have been positive by PCR for BDV (Hilbe et al., 
2006). It seems there may be more than one BDV reservoir host. Higher incidence 
of BDV infection is seen mostly in the early spring/summer and this has been 
attributed to the activities of the reservoir population or to a very long incubation 
period in the final host. 
 
Geographical distribution 
Borna disease virus infection is endemic in central Europe, i.e., Germany, 
Switzerland, Austria and Lichtenstein (Caplazi et al, 1991). However, the virus 
causing the disease is thought to be more widespread than previously thought, as 
evident by recent reports of the disease being diagnosed outside the endemic areas 
of Central Europe. The infection have been reported in racing horses in Sweden 
(Berg et al., 1999), Japan (Hagiwara et al., 1997; Taniyama et al., 2001), China 
(Hagiwara et al., 2001), Middle East (Bahmani et al., 1996; Yilmaz et al., 2002), 
USA (Kao et al., 1993) and several other parts of the world. In addition, the feline 
strain of Borna disease virus has been isolated in Sweden (Lundgren et al., 1995). 
 
Control, prevention and treatment  
Strains of BDV  
Essentially, five characterized strains of BDV exist. These are strain V (Genbank 
accession no U04608), He/80 (L27077), RW98 (AF158629-AF158633), H1766 
(AJ311523) and the highly divergent strain No/98 (AJ311524). The two common 
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laboratory strains are strain V and He/80. Strain V was found in a diseased horse 
originally from Lower Saxony, Germany, while He/80 also called Herzog/80 was 
isolated from a horse originating from Baden Wurttemberg, Germany. Strain 
RW98 was previously described as a possible new human BDV strain. It was 
isolated from the blood of a psychiatric patient (Planz et al., 1999). The highly 
divergent BDV strain, strain No/98 was isolated from a pony stallion from the 
federal state of Styria, Austria, where BDV was previously not endemic (Nowotny 
et al., 2000). Strain H1766 was called so because it was isolated from horse no 
1766 (Kolodziejek et al., 2005). 
 
Prevention and treatment of BD 
Data collected in endemic areas indicate that the separation of horses and sheep 
could prevent the outbreak of the disease (Durrwald et al., 2006). Sanitary 
conditions seem to be a critical factor in the spread of the infection. Severe losses 
had been observed in farms where several animal species had been kept together 
in one stable. Hence, the recommendation is to improve hygiene and prevent 
contact between susceptible species. This, however, does not eliminate the disease 
but contribute to reducing the spread of infection. Due to the high economic 
losses, BDV vaccines were developed in the 1920s in Germany. The first vaccines 
used were inactivated brain suspensions of experimentally infected animals. These 
vaccines did not provide adequate protection in challenge experiments. As a result, 
two live vaccines were developed. Sequel to World War II and separation of 
Germany into two countries, a lapinized live attenuated vaccine was developed in 
Tornau near Dessau, Germany. The Dessau vaccine was based on the strain from a 
naturally infected sheep. 
 
Drugs used in the treatment of BD 
Antiviral agent, amantadine sulphate is the drug of choice in the treatment of BDV 
infection. This drug was used in a patient who had BDV infection as confirmed by 
tests and also suffered from Parkinson’s syndrome with underlying mood 
disorders. Following treatment, the patient’s condition improved and the BDV 
infection was cleared but the Parkinson’s syndrome persisted. The drug has been 
found to be effective in inhibiting the wild type BDV strains from horses and 
humans. (Ludwig & Bode, 2000) 
 
Feline Borna disease or staggering disease 
A fatal neurological disorder of cats, called staggering disease, has been linked to 
BDV infection (Lundgren et al., 1995). The infection in cat is characterized by 
nonsuppurative meningoencephalitis predominantly affecting the brain stem and 
the limbic system (Lundgren, 1992). Clinically, the disease is characterized by 
hind limb incoordination and paresis, increased affection, inability to retract the 
claws and increased appetite. The clinical signs that are observed in staggering 
disease are a reflection of the multifocal involvement of the nervous system. 
Lesions in the upper or lower neurons or midbrain are responsible for the hind 
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limb incoordination and paresis. Increased affection, which is an altered 
behaviour, may be due to damage to the cortex and limbic system (Oliver & 
Mayhew, 1987). Some cats that recover from staggering disease sometimes 
develop an obesity syndrome similar to that seen in rats experimental infected with 
BDV (Kao et al., 1993). Pathological examination of the brain reveals an 
extensive adventitial mononuclear cuffing, neuronophagia and the presence of 
inflammatory nodules consisting mainly of macrophages or microglial cells 
(Lundgren, 1992). This pathological feature is typical of a viral infection. 




Diagnosis of feline Borna disease in the early days, like any other disease, relied 
on the conventional method, which was based on clinical signs together with 
histopathological demonstration of nonsuppurative meningoencephalitis. 
Histopathology continues to play a very important role in the diagnosis of BDV. It 
is usually combined with immunohistochemistry for the detection or 
demonstration of BDV specific antigens (Gosztonyi & Ludwig, 1984). The virus 
grows in a broad spectrum of cell lines and can therefore be isolated in tissue 
culture. Due to the fact that BDV is noncytolytic, presence of specific antigens in 
infected tissue cultures is detected by immunofluorescence and 
immunocytochemistry (Hirano et al., 1983; Pauli et al., 1984). With giant strides 
having been made in molecular biology, polymerase chain reaction (PCR) 
continues to be a very promising diagnostic tool for BDV. PCR compared to other 
diagnostic tools is highly sensitive, robust and rapid for detecting the virus 
(Zimmerman et al., 1994).  
Infection with BDV either natural or experimental usually elicits a very strong 
humoral response, and the antibodies that are produced can be detected by indirect 
immunofluoresence, western blotting or immunoprecipitation. Other methods that 
can be used for the diagnosis of BDV include ELISA and flow cytometric method 
for detection of BDV specific antigen in peripheral blood mononuclear cells 
(PBMC) (Bode et al., 1994; Bode et al., 1995). However, naturally infected cats 
seem to develop low or no antibody titres, while experimentally infected cats 
developed high titres (Johansson et al., 2002). Experimentally infected cats had a 
high titre of antibodies to p40 and p23 and they responded mainly to p40 whereas 
naturally infected cats had a weak humoral response and although they did 
respond to p40, the response to p23 was much stronger (Johansson et al., 2002). 
 
Aims of the project 
 
In broad terms, the aim of the project was to study the molecular epidemiology of 
Borna disease virus in Sweden. Specifically, the aim was to identify, isolate and 
subsequently characterize at least one Swedish isolate of BDV. In addition, to use 
conventional and real-time PCR to detect BDV in clinical and archive samples 
originating from feline specie. Detection of BDV in clinical samples such as 
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peripheral blood mononuclear cells would be an important step in allowing 
institution of early treatment in diseased animals. 
 
For the archive samples, demonstration of BDV by real-time RT-PCR, subsequent 
sequencing of the PCR products and carrying out a phylogenetic analysis of the 




Archive samples and incoming samples were screened by real-time RT-PCR. 
Eight samples were positive by real-time RT-PCR. Of these samples, three, 
O.407/94BG, O.388/96:3 and O.344/94:4 were used for infecting two different 
cell lines, MDCK and Vero cells, to attempt isolation of the virus by consecutive 
passaging. Virus was not detected by PCR in infected cells. However, presence of 
the virus was demonstrated in passages 10-12 in cells infected with the positive 
control; strain No/98, showing that the methodology used was adequate. Two 
other samples, O.163/05 and O.69/92:3 with the lowest cycle to threshold value 
(Ct values) were used to test six sets of primers. The primers used were those 
described by Kolodziejek et al. (2005). Three primer pairs were found to 
reproducibly amplify C6BDV cells, which are persistently infected with BDV. 
 
Conclusion 
The detection of BDV in eight positive samples from cat by real-time PCR 
confirmed that the assay is reliable for demonstration of BDV in clinical specimen. 
Though the virus was not detected upon sub-passages in cells, presence of the 
virus in later passages in the Vero cell from passage 10-12 in the positive control 
shows that other factors than the assay may have contributed to the lack of virus 
isolation. Examples of such factors could be a low amount of virus in the sample 
that would require more passages than the ones used, or unviable virus in the 
specimen (though nucleic acid would still be suitable for detection by RT-PCR). 
The classical PCR for molecular epidemiology needs further optimization as 
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Feline Borna disease, a neurological disease of cats is an infection caused by 
Borna disease virus (BDV). The infection, first reported in Sweden in 1974, 
affects other species of animals such as horses in which the disease was first 
reported. Sheep is the other natural host of the virus, but BDV infection is also 
seen in cattle, dogs, goats, donkey, and some zoo animals. The disease is widely 
speculated to be zoonotic as it is believed to affect humans as well. In Sweden, the 
infection is endemic in central part of Sweden namely in the Stockholm and 
Uppsala area, where numerous cases have been reported in the past and new cases 
continue to emerge in recent times. The importance and continued incidence and 
prevalence of the infection in cat prompted this present study. Archive and 
incoming samples from cats, horses and dogs were screened by real- time RT-
PCR. Eight positive cat samples were detected by real-time RT-PCR. Three of 
these samples were used for virus isolation and characterization, while two other 
positive samples were used to test previously described primers. In conclusion, we 
have been able to detect eight positive samples from the cat by real-time RT-PCR. 
Though the virus was not detected upon sub-passages in vero cells, demonstration 
of presence of the virus from passage 10-12 in the positive control show that other 
factors than the assay may have contributed to the lack of virus isolation The 
classical PCR for molecular epidemiology needs further optimization as reflected 
in the fact that only three primer pairs seem to work with the C6BDV used as 
positive control  
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Introduction 
In the 18th and 19th centuries in southern Germany, clinical symptoms in horses 
similar to that of Borna disease (BD) were first described. This was the first record 
of its kind as regards BDV in any part of the world. There had been an epidemic 
like outbreak in the 1890 and the first decade of the 20th century in the city of 
Borna, near Leipzig, Germany, where a large number of horses had died from the 
disease. The name Bornasche Krankheit (Borna disease) was coined from the 
district around the city where the epidemic had occurred. In the 1920s, the 
aetiology of the disease was demonstrated to be a virus (reviewed in Durrwald & 
Ludwig, 1997; Ludwig & Bode, 2000). As early as the 1950s, feline cases of 
nonsuppurative meningoencephalitis had been reported in different parts of the 
world (Hoff & Vandevelde, 1981; Truyen et al., 1990). At that time the disease 
was poorly defined and the aetiology although unknown, was assumed to be of 
viral origin. However, in 1974, a feline neurological disorder of cat with an 
unknown aetiology was described in Sweden (Kronevi et al., 1974). Cases of 
feline meningoencephalitis commonly called vingelsjuka in Swedish (staggering 
disease) continue to occur in mid Sweden even to date. In the 1990s staggering 
disease was linked to BDV infection (Lundgren et al., 1995). 
 
The etiological agent, Borna disease virus, is a single stranded negative sense 
enveloped non segmented RNA virus (Briese et al., 1994; Cubitt et al., 1994) and 
is the prototypic member of the new family Bornaviridae, within the order 
Mononegavirales (De la Torre, 1994; Schneemann et al., 1995). The virus is 
believed to be an old evolutionary pathogen that has had time to adapt to a wide 
range of mammalian hosts. The virus is highly neurotropic having affinity for the 
limbic system and the reticuloendothelial system. 
 
BDV exhibits several unique features or characteristics, among them are that the 
genome organisation and nucleotide sequence are typically similar to other 
members of the order Mononegavirales. Unlike other viruses, which replicate and 
transcribe in the cytoplasm, nuclear localization of replication and transcription is 
typical of BDV (Pyper et al., 1998). The unusually high level of sequence 
conservation (Formella et al., 2000) is unexpected for an RNA virus that has a 
high rate of replication and transcription and thus likely to mutate often. 
 
The virus seems to have wider host range than previously thought and presumably 
affects humans as well (Rott et al., 1985; Bode et al., 1995). The virus causes a 
persistent infection of the CNS with astrocytes primarily affected (Carbone et al., 
1989, and 1993). A characteristic feature of the infection is the development of a 
prominent astrocytosis (Gonzalez et al., 1997; Gosztonyi & Ludwig, 1995; 
Ludwig & Bode, 2000; Rott & Becht, 1995). In an inflammatory reaction of the 
brain, it is universally normal for astrocytes to respond to the inflammatory 
process irrespective of the aetiology. The primary role of astrocytes is to maintain 
the CNS microenvironment in order to ensure proper functioning of the neurons 
(Benveniste, 1992; Eddleston & Mucke, 1993; Schousboe et al., 1997). BDV 
establishes a non-cytolytic chronic infection in primary feline cortical astrocytes 
causing a severe and specific impairment in astrocytes ability to uptake glutamate 
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(Billaud et al., 2000). So far, all known BDV isolates are non-cytolytic and highly 
neurotropic (Lipkin et al., 1997; Ludwig & Bode, 2000; Rott & Becht, 1995). 
 
The BDV genome, which is about 8.9 kb, is the smallest among all known 
negative nonsegemented single-stranded RNA viruses. The genome organisation 
is characteristic for the order Mononegavirales. It has 6 open reading frames 
coding for 6 different proteins, i.e. p40 nucleoprotein, p24 phosphoprotein, GP18 
matrix protein, GP94 surface glycoprotein, p190 viral RNA dependent RNA 
polymerase also called the L polymerase and the 6th protein called X protein or 
p10 (Briese et al., 1994; Cubitt et al., 1994). 
 
In broad terms, the aim of the project was to study the molecular epidemiology of 
Borna disease virus in Sweden. Specifically, the aim was to identify, isolate and 
subsequently characterize at least one Swedish isolate of BDV. In addition, to use 
conventional and real-time PCR to detect BDV in clinical and archive samples 
originating from feline specie. Detection of BDV in clinical samples such as 
peripheral blood mononuclear cells would be an important step to allow institution 
of early treatment in diseased animals. 
 
For the archive samples, demonstration of BDV by real-time RT-PCR, subsequent 
sequencing of the PCR products and carrying out a phylogenetic analysis of the 




Materials and methods 
 
Samples 
Both archive and incoming clinical samples consisting of fifty samples were used 
for this project. The samples were brain, cerebrospinal fluid and lymphocytes 
stored at –70°C. Various sections of the brain had been taken from horses, dogs 
and cats. The sections of the brain taken included cerebellum, cerebrum, medulla 
oblongata, cortex and hippocampus. Incoming samples were mainly blood samples 
from horses from the Animal Hospital in Helsingborg, in the south part of 
Sweden. Lymphocytes were immediately isolated from whole blood samples using 
Lymphoprep (Axis-Shield PoC AS, Oslo, Norway) according the manufacturer’s 





Total RNA was extracted with 1000 µl of TRIzol (Invitrogen) for tissue samples 
and 750 µl for blood samples. Tissue samples were extracted by adding about 25-
50mg of tissue into a test tube to which 1000 µl of TRIzol was added. For blood 
samples, 250 µl of the blood sample was lysed in 750 µl of TRIzol. The samples 
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were homogenised, incubated for 5 min and 200 µl of chloroform was further 
added. After mixing vigorously by hand, these were centrifuged at 11,000 × g for 
15 min at 4°C. The RNA was transferred to a fresh test tube and 500 µl of 
isopropyl alcohol was added to precipitate the RNA. Following 10 minute 
incubation at room temperature, the samples were centrifuged at 11,000 × g for 30 
minutes at 4°C. The supernatant was removed and RNA was washed once with 1 
ml of 75% ethanol and centrifuged at 7,400 × g for 10 minutes at 4°C. The RNA 
pellets were air-dried and then resuspended in 25 µl of RNAse-free water. The 
samples were then diluted at a ratio of 1:5. A 5-µl aliquot was used to measure the 
RNA concentration and purity using the NanoDrop ND-1000 (NanoDrop 
Technologies, Wilmington, DE, USA). RNA was also extracted with RNeasy 




A duplex BDV real-time RT-PCR assay was used for screening of the samples 
(Wensman et al, 2004). The reactions were carried out using 2 µl of extracted 
RNA in a final volume of 25 µl containing 1 × EZ buffer (Applied Biosystems, 
Foster City, CA, USA), 2.5 mM Mn(OAc)s (Applied Biosystems), 0.08 mg/ml 
bovine serum albumin, 0.5 mM of dNTPs (GE Healthcare, Uppsala, Sweden), 0.7 
µM of each BDV p23 primer, 0.4 µM of each BDV L-gene primer, 0.3 µM of the 
BDV p23 probe, 0.4 µM of the BDV L-gene probe and 2.5 U of rTth DNA 
polymerase (Applied Biosystems). The reactions were run in a Rotor-Gene 3000 
(Corbett Research, Australia). The RT reaction was performed with an initial 
incubation of 42°C for 5 min, followed by incubation at 60°C for 20 min. These 
were then processed through 45 cycles of 5 s at 95°C, 30 s at 50°C. The data were 
analysed and presented with Rotor-Gene Real-Time Analysis Software 6.0 (Build 





Classical RT-PCR with Phusion DNA polymerase 
cDNA synthesis 
The RT reaction was performed in a final volume of 40 µl containing 500 
ng of total RNA. The RNA was mixed with 1.06 µg of random hexamers 
and 1 mM of dNTPs and incubated at 65°C for 5 min. Then a reaction mix 
containing 1 × first strand buffer, 10 mM DTT and 24 U of RNAse out 
(Invitrogen) and 200 U of reverse transcriptase, Superscript II (Invitrogen) 
was added. 
The RT reaction was performed at 42°C for 50 minutes. To inactivate the 
enzymes samples were incubated at 70°C for 15 minutes. 
 25 
The six sets of primers used for PCR were those described by Kolodziejek 
et al. (2005) and Berg et al. (2001) (see Tables 1 and 2). RNA samples 
from the two cats with the lowest cycles to threshold (Ct) values that had 
been positive by real-time RT-PCR were reverse transcribed and their 
cDNA were used to test the primers. Also, RNA extracted from the 
C6BDV cell line, persistently infected with BDV was used as a control. 
 
The PCR was performed by mixing 1µl of cDNA with 0.4 µM of each forward 
and reverse primer, 1 × Phusion buffer (Finnzymes OY, Espoo, Finland), 250 µM 
of each dNTPs, 0.5 U of Phusion DNA polymerase (Finnzymes OY) and DMPC-
treated water to a total volume of 25 µl. The cycling conditions were as follows: 
An initial denaturation step of 98°C for 30 s followed by 40 cycles of 98°C for 10 
s, 60°C for 30 s, 72°C for 30 s, with a final extension of 72°C for 5 min. The PCR 
products were run on 1.5% agarose gels in 0.5 × TBE buffer for 1 h at 110V, 
stained with ethidium bromide and then visualized on a transiluminator. The size 
of the PCR product was determined by comparing to a 100-bp DNA ladder.  
 
Table 1.Primer pairs used for the PCR and expected size of the PCR products. 
 
Primer pair Forward primer Reversed primer PCR product size (bp) 
1 BDV 1F  BDV 625r 652  
2 BDV 218F  BDV796r 579  
3 BDV587F  BDV 1161r 575  
4 BDV 778F  BDV1518r 741  
5 BDV1327F  BDV1837r 511  
6 BDV1695F  BDV2138r 444  
 
There were two non-template controls (NTC) for each reaction. In order to 
increase the sensitivity a nested RT-PCR assay, combining the BDV1f and p23B 
primers as the outer primer pair, was used. One microlitre of PCR product was 
taken from the first round of PCR and used as a template for the next round of 
PCR. PCR product from the first PCR reaction was diluted in the ratio of 1:10, and 
the rest was then purified using Wizard® SV Gel and PCR clean-up system (Cat # 
A9282 Promega). The diluted and purified PCR products were also used as 
templates for the 2nd round of PCR. The same procedure was applied to P40A and 
P40B. The thermal profile for P23A and P23B, P40A and P40B were initial 
denaturation at 95°C for 1 min, followed by 40 cycles of denaturation at 95°C for 
30 s, annealing temperature of 55°C for 30 s,  and extension at 72°C for 2 min and 
a final extension at 72°C for 5 min.  For P40C and P40D, P23C and P23D the 
thermal profile were an initial denaturation at 95°C for 1 min, followed by 
35cycles of denaturation at 95°C 30 s, an annealing temperature 60°C for 30 s, and 




Characterization of virus isolates  
Three RNA samples from cats that had been positive for the BDV by real-time 
reverse transcriptase PCR were used for virus infection and subsequent passaging 
in two different cell lines, MDCK and Vero cells. 
 
The cells were sub-cultured up to the 12th passage and at each passage cells were 
frozen down for RNA extraction, for later passaging and also lysed for preparation 
of protein extracts to check for viral proteins.  
MDCK and Vero cells were grown in (media) supplemented with 10% FCS, L-
glutamine, and containing a mixture of penicillin and streptomycin as antibiotic. 
The brain samples of the three samples from the cats that had been positive by 
real-time RT-PCR: O.407/94 bg, O.388/96:3 and O.344/96:4 were thoroughly 
homogenized using a plastic pestle. Further homogenization was done by pipe 
tting up and down several times, then 5 ml of cell culture medium was added. The 
infection was done by transferring 100 µl of brain suspension onto semi-confluent 
MDCK and Vero cells, grown in 25 cm2 tissue culture flasks. After 1 hours of 
incubation, the cells were washed twice in PBS and fresh cell culture medium was 
added. Subsequently, the cells were sub-cultured every third-fourth day. For the 
positive control, 100 µl of Vero cells infected with the No/98 strain was used to 
infect the cells following a similar procedure. The infection of the positive control 
was done after decontaminating the hood. For each of the cell lines, there were 
two controls, one positive control, strain No/98 and a negative control which was 
uninfected cell line, i.e., uninfected Vero cells and uninfected MDCK cells. 
The cells were sub-cultured up to the 12th passage and at each passage cells were 
frozen down for RNA extraction, for later passaging and also lysed for preparation 
of protein extracts to check for viral proteins. 
In parallel, uninfected MDCK and Vero cells of the same passage level as used for 




BDV real-time RT-PCR screening 
First, archived samples from cats, dogs and horses were screened using the BDV 
real-time RT-PCR assay. Following the extraction of RNA and the detection of the 
Borna disease virus gene by duplex real-time RT-PCR, 8 samples were positive 
for the P23 region (Fig 1a). The RNA of these samples was reverse transcribed 





Fig. 1a. Real-time RT-PCR detection of Borna disease virus P23-gene. 1, 
O.338/94:4; 2, O.388/96:3; 3, O.407/94BG; 4, O.388/96:1; 5, O.334/96:2; 6, 





Fig. 1b. Demonstration of BDV by real-time RT-PCR. Two samples with low Ct 
values were used to test primers for generation of PCR products for molecular 
epidemiology: (1, O.69/92:3; 2, O.407/94BG; 3, O.163/05; 4, O.388/96:1).  
 
Two samples, O.163/05 and O.69/92:3, with the lowest cycles to threshold values 
(Ct values) were used for testing the primers (Fig 1b), while three samples 
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O.407/94 BG, O.388/96:3, O.344/96:4 were used for infecting the two cell lines, 
MDCK and Vero cells (Fig. 1a).  
 
 
Optimisation of classical PCRs for molecular epidemiology 
For molecular epidemiology, primers described in Kolodziejek et al. (2005) and 
Berg et al. (2001) were used. The two feline samples with the lowest threshold Ct 
values, indicating the highest presence of viral RNA, were used in an initial test 
(Fig 2). PCR products were only seen clearly using primer pairs 3, while Primer 
pair 4 and 6 produced faint bands  and in one case (primer pair 3) the size was 





Fig. 2. Testing of the primers. Lanes 1 and 2: primer pair 1; lanes 3 and 4:: primer 
pair 2; lanes 5 and 6: primer pair 3: lanes 7 and 8: primer pair 4; lanes 9 and 
10:primer pair 5; lanes 11 and 12: primer pair 6 (as listed in Table 1). 
 
The primers were originally designed to fit the BDV strain V. Therefore, the 
C6BDV cells infected with BDV He/80, which has a similar sequence as strain V 
was used to further test the primers. This test showed that only the three first 
primer pairs were working optimally (see Fig 3). Our observations revealed that 
the forward primers seem to be working at least for the first three pairs. We then 
decided to use the forward primer BDV587F to test if the reverse primers were 
working. Also included in this test was forward primer, BDV778, which seem to 
work. It was combined with BDV1161r the last reverse primer, which seem to 
work. This primer pair combination was the only one that seems to work 
producing PCR product of the expected size. In this experiment primer pair 3 was 















Fig. 3. Testing of the primers with the C6BDV cells and two samples with the 
lowest ct value. Lanes 1, 2, 7 and 8: primer pair 1; lanes 3, 4, 9 and 10: primer pair 




Fig. 4.  Testing of the reverse primers. Lane 1 and 6, DV587 & BDV1161 
(control); Lane 2 and 7, BDV587 and 1518r; Lane 3 and 8, BDV 587 and 1837r; 
Lane 4 and 9, BDV 587 and 2138r; Lane 5 and 10, BDV778 and 1161r. 
 
Characterization of virus isolates 
Brain suspensions of three naturally infected cats positive by real-time RT-PCR 
were transferred to MDCK and Vero cells in order to try to isolate the virus. The 
BDV strain No/98 was used as a positive control and uninfected cells treated the 
same way as the infected was used as negative controls. 
 
RNA materials frozen down from passage 1 to 12 for the uninfected and infected 
cell lines, MDCK and Vero cells were subjected to real-time RT-PCR. C6BDV 
cells were also used along with strain No/98 as positive controls. In each PCR, 
there were two non-template controls (water). BDV could not be detected in any 
of the uninfected and infected cell lines but virus was demonstrated in later 





Discussion and conclusion 
 
Compared to the positive control, C6BDV cells, the eight samples that were 
positive by real-time RT-PCR had high cycle threshold values. This probably 
might be an indication that the samples contain small amount of viral load in the 
first instance. 
 
Our inability to detect BDV by real-time RT-PCR from RNA materials frozen 
down from various cell passages might be due to small amount of viral load in the 
samples, in spite of the fact that the three samples that were used for infecting the 
different cell lines had the lowest Ct values. Other possible explanations for the 
failure to demonstrate BDV gene in the infected cell lines could be due to the fact 
that the three samples that were used for the infection were obtained from the 
brain and as we know the brain contains a lot of cellular debris such as fat and 
some other toxic materials and other contaminants. These contaminants might 
have inhibited the PCR reaction. Perhaps, it is the same line of thought that 
influences the use of lymphocytes rather than blood sample for diagnosis of BDV. 
This fact might also have led to the purification of the Japanese human brain 
samples first by ultracentrifugation to get the ribonucleoproteins before extracting 
the isolates (Nakamura et al., 2000). Cellular debris from the brain might have 
affected the cells and that could be a reason for not detecting the virus. BDV 
grows in several established cell lines but the feline strain has been demonstrated 
to grow only in embryonic mink brain cells. The virus was detected in the third 
passage but later disappeared (Lundgren et al., 1995). It is not known if the virus 
grows in other cell lines, which we did not test or use. 
 
However, BDV was demonstrated though in the later passage of the positive 
control, strain No/98, which is an indication that our systems do work. Strain 
No/98 is however a cleaner material compared to the brain suspension from the 
cat. 
 
The unspecific banding that was observed on the gel electrophoresis following 
PCR with cDNA from feline virus might be due to primer mismatches. The 
primers had been designed based on the nucleotide sequence of strain V. This was 
somewhat confirmed when the primers were tested using the C6BDV cells, 
persistently infected with a strain similar in sequence with the V strain. The 
banding was more specific and the PCR product corresponded to the expected 
sizes. 
 
Characterization of a feline strain of BDV would enable comparison with other 
strains that have been sequenced particularly from the horse, possibly emphasising 
the similarities and differences. It might also be important in tracing the origin of 
the infection. The development of a good PCR for diagnosis is important 
particularly in intra vitam diagnosis of the disease. The PCR system in place 
should be one that can detect all possible strains of BDV from different species of 
animals. Perhaps the incidence and prevalence of BDV in general and feline BDV 
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in particular has been underestimated due partly to the fact that the PCR systems 
currently in use has failed to detect the BDV, as a result of the numerous problems 
associated with the disease. 
 
It would be interesting and of scientific benefit to characterize a feline strain of 
BDV isolate as this would aid in our understanding of the pathogenesis, 
epidemiology, diagnosis, treatment and possibly vaccine development in the 
nearest future. 
 
In conclusion, we have by real-time RT-PCR been able to detect eight positive 
samples from the cat. Though we were unable to isolate the virus in later passages 
in the Vero cells, we did demonstrate the virus from 10-12 passages of the strain 
No/98, the positive control. The classical PCR for molecular epidemiology needs 
further optimization as reflected in the fact that only three primer pairs seem to 
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